Spotlight on AbbVie: Analyzing the Surge in Options Activity
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $165.0 to $195.0 in the last 30 days. Financial giants have made a conspicuous bullish move on AbbVie. Our analysis of options history for AbbVie (NYSE:ABBV) revealed 8 unusual trades.
金融巨頭對艾伯維公司採取了明顯的看好舉動。我們對艾伯維公司（NYSE:ABBV）期權歷史進行分析，發現了8筆異常交易。
Delving into the details, we found 37% of traders were bullish, while 12% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $325,314, and 4 were calls, valued at $527,350.
深入細節，我們發現37%的交易者持看好態度，而12%顯示出看跌傾向。在我們發現的所有交易中，有4筆爲看跌期權，價值 $325,314，以及4筆爲看漲期權，價值 $527,350。
Projected Price Targets
預計價格目標
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $165.0 to $195.0 for AbbVie during the past quarter.
分析這些合約的成交量和未平倉合約量，似乎大型交易者一直關注艾伯維公司在過去一個季度內的價格區間從$165.0到$195.0。
Volume & Open Interest Trends
成交量和未平倉量趨勢
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $165.0 to $195.0 in the last 30 days.
在交易期權時，查看成交量和未平倉合約量是一個強大的舉措。這些數據可以幫助您跟蹤給定行權價格下艾伯維公司期權的流動性和興趣。下面，我們可以觀察過去30天內所有艾伯維公司大手交易的看漲和看跌期權的成交量和未平倉合約量的演變，分別在$165.0到$195.0的行權價格範圍內。
AbbVie Option Volume And Open Interest Over Last 30 Days
艾伯維期權成交量和未平倉利息過去30天的變化
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | SWEEP | BEARISH | 09/20/24 | $28.4 | $27.15 | $28.0 | $165.00 | $361.2K | 1.4K | 29 |
| ABBV | PUT | TRADE | BULLISH | 12/20/24 | $3.8 | $3.7 | $3.71 | $180.00 | $204.0K | 8 | 553 |
| ABBV | CALL | TRADE | BULLISH | 12/20/24 | $8.1 | $8.05 | $8.1 | $195.00 | $101.2K | 363 | 125 |
| ABBV | PUT | TRADE | NEUTRAL | 09/20/24 | $2.12 | $1.83 | $1.95 | $195.00 | $58.5K | 3.3K | 1.0K |
| ABBV | PUT | TRADE | NEUTRAL | 01/16/26 | $18.25 | $17.75 | $17.98 | $190.00 | $35.9K | 646 | 20 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 艾伯維公司 | 看漲 | SWEEP | 看淡 | 09/20/24 | $28.4 | $27.15 | $28.0 | 165.00美元 | $361.2千美元 | 1.4千 | 29 |
| 艾伯維公司 | 看跌 | 交易 | 看好 | 12/20/24 | $3.8 | $3.7 | $3.71 | 180.00美元 | $204,000 | 8 | 553 |
| 艾伯維公司 | 看漲 | 交易 | 看好 | 12/20/24 | $8.1 | $8.05 | $8.1 | $195.00 | $101.2千 | 363 | 125 |
| 艾伯維公司 | 看跌 | 交易 | 中立 | 09/20/24 | $2.12 | $1.83 | $1.95 | $195.00 | $58.5K | 3.3K | 1.0K |
| 艾伯維公司 | 看跌 | 交易 | 中立 | 01/16/26 | $18.25 | $17.75 | $17.98 | $190.00 | $35.9K | 646 | 20 |
About AbbVie
關於艾伯維公司
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
AbbVie是一家藥品公司，其在免疫學（包括Humira、Skyrizi和Rinvoq）和腫瘤學（包括Imbruvica和Venclexta）方面擁有強大的業務。該公司於2013年初從Abbott分拆而來。2020年收購雅培使其在美容業務（包括Botox）中新增了一些產品和藥品。
Following our analysis of the options activities associated with AbbVie, we pivot to a closer look at the company's own performance.
在對艾伯維公司相關期權活動進行分析後，我們轉而更近距離地查看該公司的表現。
Current Position of AbbVie
艾伯維公司的當前頭寸
- With a trading volume of 3,370,211, the price of ABBV is down by -0.39%, reaching $192.86.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 35 days from now.
- ABBV的交易量爲3,370,211，價格下跌-0.39%，達到192.86美元。
- 目前的RSI值表明該股票目前處於超買和超賣之間的中立狀態。
- 下一份業績將於35天后公佈。
Expert Opinions on AbbVie
關於艾伯維公司的專家意見
In the last month, 1 experts released ratings on this stock with an average target price of $209.0.
在過去一個月裏，1位專家發佈了對該股票的評級，平均目標價爲209.0美元。
Turn $1000 into $1270 in just 20 days?
在短短20天內，將1000美元變成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on AbbVie with a target price of $209.
20年期權交易專家揭示了他的一行圖表技術，顯示何時買入和賣出。複製他的交易，平均每20天盈利27%。點擊這裏獲取.* 派傑投資的分析師保持對艾伯維公司的股票評級爲超配，目標價爲209美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with Benzinga Pro for real-time alerts.
交易期權涉及更高風險，但同時也提供實現更高利潤的潛力。精明的交易者通過持續教育、戰略性交易調整、利用各種因子以及保持對市場動態的關注來減輕這些風險。使用Benzinga Pro跟蹤AbbVie的最新期權交易以獲取實時警報。
譯文內容由第三人軟體翻譯。